RI

99

+2.34%↑

SONE

0.95

+1.39%↑

ONTEX

8.3

+1.84%↑

RI

99

+2.34%↑

SONE

0.95

+1.39%↑

ONTEX

8.3

+1.84%↑

RI

99

+2.34%↑

SONE

0.95

+1.39%↑

ONTEX

8.3

+1.84%↑

RI

99

+2.34%↑

SONE

0.95

+1.39%↑

ONTEX

8.3

+1.84%↑

RI

99

+2.34%↑

SONE

0.95

+1.39%↑

ONTEX

8.3

+1.84%↑

Search

Anheuser-Busch InBev SA/NV

Closed

Sector Consumer defensive

51.68 2.09

Overview

Share price change

24h

Current

Min

51.54

Max

51.7

Key metrics

By Trading Economics

Income

598M

2.1B

Sales

-287M

15B

P/E

Sector Avg

16.669

44.075

EPS

0.98

Dividend yield

1.62

Profit margin

13.764

Employees

155,000

EBITDA

689M

4.2B

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+17.87 upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

1.62%

3.30%

Next Earnings

26 Feb 2025

Market Stats

By TradingEconomics

Market Cap

-1.5T

100B

Previous open

49.59

Previous close

51.68

News Sentiment

By Acuity

59%

41%

124 / 154 Consumer defensive

Anheuser-Busch InBev SA/NV Chart

Past performance is not a reliable indicator of future results.

Related News

3 Jan 2025, 14:04 UTC

Major Market Movers

Alcohol Stocks Fall After Surgeon General Warns on Cancer Links

31 Oct 2024, 23:43 UTC

Earnings

Bud Light Owner's U.S. Sales Bounce Back After Boycott -- 4th Update

31 Oct 2024, 12:25 UTC

Earnings

Bud Brewer AB InBev's Shares Fall After China Weakness Drags Sales -- 3rd Update

31 Oct 2024, 08:05 UTC

Earnings

Bud Brewer AB InBev's Sales Volumes Drop More Than Expected, Dragged by China Weakness -- 2nd Update

31 Oct 2024, 07:21 UTC

Earnings

Correction to AB InBev Article

31 Oct 2024, 06:54 UTC

Earnings

Bud Brewer AB InBev Misses Sales Expectations, Dragged by China Weakness -- Update

3 Feb 2025, 14:59 UTC

Earnings

Constellation Brands' Earnings Could Get Punched by Tariffs. The Stock Is Falling. -- Barrons.com

3 Jan 2025, 13:20 UTC

Top News

Update: Bud and Molson Stocks Fall as Surgeon General Issues Advisory on Alcohol's Link to Cancer -- Barrons.com

3 Jan 2025, 12:54 UTC

Top News

Bud and Molson Stocks Fall as Surgeon General Issues Advisory on Alcohol's Link to Cancer -- Barrons.com

9 Dec 2024, 10:33 UTC

Market Talk

European Beverage Stocks Likely to Outperform in 2025 -- Market Talk

8 Nov 2024, 19:43 UTC

Market Talk
Earnings

Molson Coors' Underperformance Partly Due to Volume Share Decline -- Market Talk

31 Oct 2024, 15:18 UTC

Earnings

Bud Light Boycott Eases but AB InBev Has a Fresh Problem -- Barrons.com

31 Oct 2024, 10:25 UTC

Earnings

Bud Light Boycott Eases But AB InBev Has Fresh Problem. Stock Falls After Earnings. -- Barrons.com

31 Oct 2024, 09:35 UTC

Market Talk
Earnings

AB InBev's Earnings Miss Looks Out of Character -- Market Talk

31 Oct 2024, 08:07 UTC

Market Talk
Earnings

AB InBev's Positive U.S. Performance Surprises Despite China Drag -- Market Talk

31 Oct 2024, 06:19 UTC

Earnings

Correct: AB InBev 3Q Net Pft $2.07B

31 Oct 2024, 06:19 UTC

Earnings

Correct: AB InBev 3Q Rev $15.05B

31 Oct 2024, 06:08 UTC

Earnings

AB InBev: Ebitda Lifted by Production Cost Efficiencies and Disciplined Overhead Management

31 Oct 2024, 06:07 UTC

Earnings

AB InBev: Overall Volume Performance Hit by Soft Consumer Environment in China and Argentina

31 Oct 2024, 06:06 UTC

Earnings

AB InBev: Revenue Supported by Management Initiatives and Ongoing Premiumization

31 Oct 2024, 06:05 UTC

Earnings

Analysts Saw AB InBev Net Pft at $1.92B

31 Oct 2024, 06:05 UTC

Earnings

AB InBev 3Q Net Pft $1.47B

31 Oct 2024, 06:05 UTC

Earnings

Analysts Saw AB InBev 3Q Rev $15.55B

31 Oct 2024, 06:05 UTC

Earnings

AB InBev 3Q Rev $15.57B

31 Oct 2024, 06:05 UTC

Earnings

AB InBev Had Seen 2024 Ebitda Growth Between 4%-8%

31 Oct 2024, 06:04 UTC

Earnings

AB InBev Sees 2024 Ebitda Growth Between 6%-8%

31 Oct 2024, 06:04 UTC

Earnings

AB InBev Narrows 2024 View

31 Oct 2024, 06:04 UTC

Earnings

AB InBev Launches $2B Share Buyback Program

31 Oct 2024, 06:03 UTC

Earnings

Analysts Saw AB InBev 3Q Adj EPS $0.92

31 Oct 2024, 06:03 UTC

Earnings

AB InBev 3Q Adj EPS $0.98

Peer Comparison

Price change

Anheuser-Busch InBev SA/NV Forecast

Price Target

By TipRanks

17.87% upside

12 Months Forecast

Average 61 EUR  17.87%

High 70 EUR

Low 50 EUR

Based on 13 Wall Street analysts offering 12 month price targets forAnheuser-Busch InBev SA/NV - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

13 ratings

8

Buy

2

Hold

3

Sell

Sentiment

By Acuity

124 / 154 Consumer defensive

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Anheuser-Busch InBev SA/NV

Anheuser-Busch InBev SA/NV produces, distributes, exports, markets, and sells beer and beverages. It offers a portfolio of approximately 500 beer brands, which primarily include Budweiser, Corona, and Stella Artois; Beck's, Hoegaarden, Leffe, and Michelob Ultra; and Aguila, Antarctica, Bud Light, Brahma, Cass, Castle, Castle Lite, Cristal, Harbin, Jupiler, Modelo Especial, Quilmes, Victoria, Sedrin, and Skol brands. The company operates in North America, Middle America, South America, Europe, the Middle East, Africa, and the Asia Pacific. The company was founded in 1366 and is headquartered in Leuven, Belgium.